{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:47:09Z","timestamp":1785422829223,"version":"3.56.0"},"reference-count":20,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Nevada, Reno School of Medicine Open Access Fund"},{"id":[{"id":"https:\/\/ror.org\/01keh0577","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Savitt Medical Library Bridge Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Human papillomavirus (HPV) is a well-established risk factor for oropharyngeal squamous cell carcinoma (OPSCC), with p16 expression serving as a reliable surrogate marker for HPV involvement and an important prognostic indicator. While data exist on the demographic and clinical features of p16-positive OPSCCs on a national scale, limited data exist for Nevada. Methods: This retrospective study evaluated the relationship between p16 positivity and OPSCC presentation in Northern Nevada, with specific attention to associations between p16 status, sex, socioeconomic factors, smoking history, and presenting symptoms. We reviewed medical records of 296 patients diagnosed with OPSCC with concomitant HPV testing at the Renown Regional Medical Center from 2014\u20132024. Variables of interest included sex, age at diagnosis, smoking pack-years, Nevada census-based income quintile, county of residence, and initial symptoms such as dysphagia and sore throat. Multivariate logistic regression was performed to assess associations between these variables and p16 status. Conclusions: We found that sex was the only variable significantly associated with p16 positivity: females had significantly lower odds of being p16-positive compared to males (OR: 0.36, 95% CI: 0.20\u20130.65, p = 0.001). This finding of sex-based disparity in HPV-related OPSCC is consistent with national trends. This study is limited by its regional focus and lack of data on other social determinants of health. Nonetheless, the results underscore the importance of gender-informed prevention strategies and highlight the need for further research into the biological and behavioral contributors to this disparity.<\/jats:p>","DOI":"10.3390\/jcm15135060","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:55:11Z","timestamp":1782780911000},"page":"5060","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Higher Prevalence of p16-Positive OPSCC Among Males in Northern Nevada: A Regional Epidemiological Study"],"prefix":"10.3390","volume":"15","author":[{"given":"Samantha","family":"Chang","sequence":"first","affiliation":[{"name":"Reno School of Medicine, University of Nevada, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1783-4584","authenticated-orcid":false,"given":"Steven T.","family":"Cho","sequence":"additional","affiliation":[{"name":"Reno School of Medicine, University of Nevada, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0761-9477","authenticated-orcid":false,"given":"Nicholas","family":"Bazett","sequence":"additional","affiliation":[{"name":"Reno School of Medicine, University of Nevada, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Denney","sequence":"additional","affiliation":[{"name":"Reno School of Medicine, University of Nevada, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Harspter","sequence":"additional","affiliation":[{"name":"Reno School of Medicine, University of Nevada, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadya","family":"Vinsdata","sequence":"additional","affiliation":[{"name":"Reno School of Medicine, University of Nevada, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Wrye","sequence":"additional","affiliation":[{"name":"Reno School of Medicine, University of Nevada, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Thomas","sequence":"additional","affiliation":[{"name":"Pennington Cancer Institute, Reno, NV 89502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ijc.34763","article-title":"Human papillomavirus and p16","volume":"154","author":"Lu","year":"2024","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"Plummer","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jclinpath-2018-205216","article-title":"\u00a0p16","volume":"71","author":"Serra","year":"2018","journal-title":"Clin. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/cncr.34124","article-title":"Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time","volume":"128","author":"Tewari","year":"2022","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"de C Ferreira, C., Dufloth, R., de Carvalho, A.C., Reis, R.M., Santana, I., Carvalho, R.S., and Gama, R.R. (2021). Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0253418"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1200\/JCO.22.02625","article-title":"Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States","volume":"41","author":"Chaturvedi","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.oraloncology.2019.05.016","article-title":"Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment","volume":"95","author":"Windon","year":"2019","journal-title":"Oral Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/PAS.0b013e318253a2d1","article-title":"Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials","volume":"36","author":"Jordan","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ijc.30442","article-title":"The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma","volume":"140","author":"Liederbach","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"World Health Organization (2009). WHO position on HPV vaccines. Vaccine, 27, 7236\u20137237.","DOI":"10.1016\/j.vaccine.2009.05.019"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/joim.13010","article-title":"A global epidemic increase of an HPV-induced tonsil and tongue base cancer-potential benefit from a pan-gender use of HPV vaccine","volume":"287","author":"Du","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Carlander, A.F., Jakobsen, K.K., Bendtsen, S.K., Garset-Zamani, M., Lynggaard, C.D., Jensen, J.S., Gr\u00f8nh\u00f8j, C., and Buchwald, C.V. (2021). A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide. Viruses, 13.","DOI":"10.3390\/v13071326"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chen, G., Wu, B., Dai, X., Zhang, M., Liu, Y., Huang, H., Mei, K., and Wu, Z. (2021). Gender Differences in Knowledge and Attitude towards HPV and HPV Vaccine among College Students in Wenzhou, China. Vaccines, 10.","DOI":"10.3390\/vaccines10010010"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.vaccine.2017.12.043","article-title":"The vaccine hesitancy scale: Psychometric properties and validation","volume":"36","author":"Shapiro","year":"2018","journal-title":"Vaccine"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Grandahl, M., and Nev\u00e9us, T. (2021). Barriers towards HPV Vaccinations for Boys and Young Men: A Narrative Review. Viruses, 13.","DOI":"10.3390\/v13081644"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","article-title":"Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists","volume":"142","author":"Lewis","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1200\/JCO.2024.42.16_suppl.10507","article-title":"Effects of HPV vaccination on the development of HPV-related cancers: A retrospective analysis of a United States-based cohort","volume":"42","author":"Dekloe","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"Kreimer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009\u20132010","volume":"307","author":"Gillison","year":"2012","journal-title":"JAMA"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/5060\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:56:42Z","timestamp":1782802602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/5060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":20,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcm15135060"],"URL":"https:\/\/doi.org\/10.3390\/jcm15135060","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}